First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*Miyako Satouchi, Katsuyuki Hotta, Keisuke Aoe et al.|Cancer Science|2021Cited by 18
Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302Yosuke Kawashima, Shunichi Sugawara, Toshiyuki Harada et al.|International Journal of Clinical Oncology|2020Cited by 4